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The complete amino acid sequences of two potassium channel proteins from NGlOE-15 neuroblastoma-glioma hybrid cells have been deduced 
by cloning and sequencing the cDNAs. One of these proteins (NGKZ) is structurally more closely related to the Drosophila Show gene product 
than to the Shaker and Shah gene products, whereas the other (NGKl) is identical with a rat brain potassium channel protein (BK2) which is 
more closely related to the Drosophila Shaker gene product. mRNAs derived from both the cloned cDNAs, when injected into Xenopus oocytes, 
direct the formation of functional potassium channels with properties of delayed rectifiers. 
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1. INTRODUCTION 
Voltage-gated potassium channels in excitable mem- 
branes play important roles in the control of cellular ex- 
citability [l]. Recently, the primary structures of some 
potassium channel proteins from Drosophila 12-61 and 
from mammalian brain [7-l l] have been elucidated by 
cloning and sequencing the cDNAs. mRNAs derived 
from Drosophila Shaker cDNAs [12-141 and from rat 
brain cDNAs [10,11,15,16] direct the formation of 
functional potassium channels in Xenopus oocytes. The 
present investigation deals with cloning and sequence 
analysis of two cDNAs encoding distinct potassium 
channel proteins from mouse neuroblastoma x rat 
glioma hybrid cells (NG 108- 15) [ 171 and with functional 
expression of the cloned cDNAs. The evolutionary rela- 
tionships among voltage-gated potassium channel pro- 
teins are discussed. 
2. MATERIALS AND METHODS 
2.1. Cloning and sequencing of cDNAs 
NGlOS-15 cells were cultured and differentiated in the presence of 
1 mM theophylline and 10 /rM prostaglandin Ei as in [17]. Total 
RNA was extracted [18], and poly(A)+ RNA isolated [19]. Randomly 
primed cDNA libraries were constructed in phage XZAPII 
(Stratagene) using poly(A)+ RNA as template. Double-stranded 
cDNA, prepared with the cDNA synthesis ystem (Bethesda Research 
Laboratories), was methylated by EcoRI methylase, blunted by T4 
DNA polymerase and ligated with the EcoRI linker dGGAATTCC. 
After EcoRI digestion, the cDNA was passed through a Sepharose 
CL-4B column. Fractions longer than - 0.4 kilobase pairs (kb) were 
pooled and ligated into the vector. The initial screening of a cDNA 
library was effected by hybridization at 50°C with a synthetic DNA 
probe prepared as follows. Two overlapping 105-mers (I, II) which 
comprise portions of the MBKl cDNA [7] encoding a mouse brain 
potassium channel protein were prepared with an automatic DNA 
synthesizer (Applied Biosystems); I represents nucleotides 862-966 of 
the message strand, and II the sequence complementary to nucleotides 
937-1041. After annealing the single strands, the complementary se- 
quences were labeled by a fill-in reaction using a Klenow fragment 
and [(r-32P]dCTP as in (201. For the screening of a second cDNA 
library, cDNA clones isolated initially served as probes for hybridiza- 
tion at 50°C. cDNA inserts from isolated clones were subcloned into 
pBluescript SK(-) by in vivo excision according to the Stratagene 
product protocol. Nested deletions were made [21] and DNA sequenc- 
ing was carried out on both strands by the dideoxy chain termination 
method [22]. Blot hybridization analysis of poly(A)+ RNA from 
NG108-15 cells was performed as in [23], using the EcoRI(IlS)/ 
BamHI(1612) fragment from ANGK2.19A4 or the PstI(vector)/ 
BamHI(1612) fragment from pSPNGK2 as probe; restriction endonu- 
clease sites are identified by numbers (in parentheses) indicating the 
5 ‘-terminal nucleotide generated by cleavage. 
2.2. Synthesis of specific mRNAs 
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The recombinant plasmids pSPNGK1 and pSPNGK2, used for the 
synthesis of mRNAs specific for the NGKl and the NGK2 protein (see 
section 3). respectively, were constructed as follows. pSP64@olyA) 
(Promega) was digested with EcoRI, blunted by T4 DNA polymerase 
and ligated with the XhoI linker dCCTCGAGG. The resulting plas- 
mid was cleaved with XhoI and ligated again to yield pSP64AX. The 
1.8-kb hruII(- 4O)/BamHI(vector) fragment from hNGKl.23C2 
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and the 3.0-kb BumHI/HincII fragment from pSP64AX were ligated 
to yield pSPNGK1. The NarI(-7)/NurI(508) fragment from 
ANGKZ. 18Al was blunted by T4 DNA polymerase and cleaved by 
HindHI. The resulting 0.23-kb fragment, the HindIII(224)/ 
EcoRI(815) fragment from ANGK2. 18A1, the EcoRI(815)/ 
BamHI(1612) fragment from hNGK2.19A4 and the 3.0-kb BarnHI/ 
HincII fragment from pSP64AX were ligated to yield pSPNGK2. 
NGKl-specific and NGKZ-specific mRNAs were synthesized in vitro, 
using XhoI-cleaved pSPNGK1 and pSPNGK2, respectively, as tem- 
plates [24]. Transcription was primed with the cap dinucleotide 
G(5 ‘)ppp(5 ‘)G (0.5 mM) [25]. 
2.3. Electrophysiological measurements 
Each of the specific mRNAs was injected into Xenopus laevis 
oocytes (mRNA concentration, 25 ng/pl; average volume injected per 
oocyte, - 50 nl). The injected oocytes were incubated at 19°C for 2-3 
days in modified Barth’s medium [26] containing cefmenoxime 
(0.1 mg/ml). Whole-cell currents were measured using a conventional 
two-microelectrode voltage clamp. The chamber was continuously 
perfused with normal frog Ringer solution (115 mM NaCI, 2.5 mM 
KCl, 1.8 mM CaClz, 10 mM HEPES, pH adjusted to 7.2 with 
NaOH). For ion substitution experiments, the concentration of KC1 
was raised at the expense of NaCI. The final KC1 concentration rang- 
ed from 5 mM to 100 mM. Effects of pharmacological agents were 
assessed by measuring the current amplitudes at the end of 200-ms 
voltage steps to 0 mV. Whole-cell current records were low-pass 
filtered at 3 kHz and sampled at 2.5 kHz. For single-channel recor- 
ding, oocytes were immersed in a nominally Cazf-free K+ solution 
(100 mM KCl, 10 mM EGTA, 10 mM HEPES, pH adjusted to 7.2 
with KOH) and inside-out patches were excised into the same solu- 
tion. Patch pipettes were filled with normal frog Ringer solution. All 
electrophysiological measurements were carried out at 22 + 1 “C essen- 
tially following the procedures described in [ 151. 
3. RESULTS AND DISCUSSION 
A randomly primed cDNA library derived from 
NG108-15 cell poly(A)+ RNA was screened by 
hybridization with a synthetic DNA probe comprising a 
partial cDNA sequence for a mouse brain potassium 
channel protein (see section 2.1). From - 5 x 10’ pla- 
ques, two clones (ANGKl a Xl andh2NGK2 - 5Bl) were 
isolated. A second randomly primed cDNA library 
( - 3 x lo6 plaques) was screened by hybridization with 
the cDNA inserts of the initial clones, yielding two 
clones (including XNGKl .23C2) that hybridized with 
hNGKl.5Cl and six clones (including hNGK2=18Al 
and ANGK2.19A4) that hybridized with XNGK2.5Bl. 
Nucleotide sequence analysis of clones XNGKl .23C2 
and hNGK1 - 5Cl revealed that they encode a protein 
composed of 499 amino residues (NGKl) whose se- 
quence is identical with that of the rat brain BK2 pro- 
tein reported previously [9]. 
Fig. 1 shows the cDNA sequence ncoding the NGK2 
protein, determined with clones XNGK%.18Al, 
ANGK2.19A4 and XNGKZ - 5B1, together with the 
deduced amino acid sequence. The translational initia- 
tion site was assigned to the first ATG triplet that ap- 
pears downstream of a nonsense codon, TAA 
(nucleotide residues - 15 to - 13). The nucleotide se- 
quence surrounding the initiating codon agrees 
reasonably well with the consensus sequence [27]. A 
38 
translational termination codon, TGA, occurs in the 
frame after codon 511 specifying isoleucine. Thus the 
NGK2 protein is composed of 5 11 amino acid residues 
(including the initiating methionine) and has a 
calculated M, of 57 925. The size of the NGK2 mRNA 
was estimated to be - 7000 nucleotides by blot 
hybridization analysis of poly(A) + RNA from 
NG108-15 cells. 
The NGK2 protein, like other potassium channel pro- 
teins [2-111, has a basic structure corresponding to a 
single internal repeat of the sodium channel and the 
calcium channel [28,29]. It contains five hydrophobic 
segments (Sl, S2, S3, S5 and S6) and one positively 
charged segment (S4). The conserved charged residues 
in segment S2 and in segment S3 are also retained. The 
sequence similarity observed suggests that the NGK2 
protein has the same transmembrane topology as pro- 
posed for the single internal repeats of the other 
voltage-gated ionic channels and that it forms a homo- 
or heteromultimer to surround a central pore as a chan- 
nel. This model is consistent with both the two potential 
N-glycosylation sites (asparagine residues 220 and 229) 
being located on the extracellular side of the membrane. 
Fig.2 shows an alignment of the amino acid sequence 
of the NGK2 protein with those of the Drosophila 
Shaw, Shaker and Shab proteins and of the mammalian 
RCKl, BK2 and drkl proteins. The amino acid se- 
quence of the NGK2 protein is more closely related to 
that of the Shaw protein (56% amino acid identities) 
than to those of the other potassium channel proteins 
(43%-45% amino acid identities). On the basis of the 
sequence alignment, a phylogenetic tree representing 
the evolutionary relationships among the seven 
potassium channel proteins was inferred by the 
neighbor-joining method [30], as shown in fig.3. Accor- 
ding to the phylogenetic tree, known members of the 
potassium channel family are classified into three sub- 
families: NGK2/Shaw subfamily, RCKl . BK2/Shaker 
subfamily and drkl/Shab subfamily. From the 
phylogenetic positions of the divergence of mammalian 
and Drosophila genes, it is evident that the three sub- 
families diverged before the separation of vertebrates 
and insects. After this separation, mammalian genes 
belonging to the RCKl . BK2/Shaker subfamily further 
diverged during vertebrate evolution. The relationship 
between NGK2 and Shaw (56% amino acid identities) is 
less close than that between drkl and Shab (720/o), be- 
tween RCKl and Shaker (82%) or between BK2 and 
Shaker (80%). Thus it remains possible that NGK2 is 
not a mammalian counterpart of Shaw. Of interest 
would be the evolutionary relationships among Shal, 
another Drosophila potassium channel gene [6], and 
NGK2 and the other members of the potassium channel 
family. 
mRNAs specific for the NGKl and for the NGK2 
protein were synthesized by transcription in vitro of the 
cloned cDNAs and were injected into Xenopus oocytes. 
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5'-----CCGCGGTCCTCTGTGC -121 
CCCCCGACGGCTGGGGGW\GGGGGGAAGAGGCCCTGCGCCCCCCTCCCCGTCGCC~CTCCCCCTGGCGGCAGCTCCCATGGGTGTCGCTGGGCCGCGCCATGCCTAAGGGGGCGCCGCG 
1 10 20 30 
Met Gly Gln Gly Asp Glu Ser Glu Arg Ile Val Ile Asn Val Gly Gly Thr Arg His Gln Thr Tyr Arg Ser Thr Leu Arg Thr Leu Pro 
ATG GGC CAA GGG GAC GAG AGC GAG CGC ATC GTG ATC AAC GTG GGC GGC ACG CGC CAC CAG ACG TAC CGC TCG ACG CTG CGC ACG CTG CCC 
40 50 60 
Gly Thr Arg Leu Ala Trp Leu Ala Glu Pro Asp Ala His Ser His Phe Asp Tyr Asp Pro Arg Ala Asp Glu Phe Phe Phe Asp Arg His 
GGC ACG CGG CTT GCC TGG CTG GCA GAG CCG GAC GCC CAC AGC CAC TTC GAC TAT GAC CCG CGT GCC GAC GAG TTC TTC TTC GAC CGC CAC 
70 80 90 
Pro Gly Val Phe Ala His Ile Leu Asn Tyr Tyr Arg Thr Gly Lys Leu His Cys Pro Ala Asp Val Cys Gly Pro Leu Tyr Glu Glu Glu 
CCG GGC GTC TTC GCT CAC ATC CTG AAC TAT TAC CGC ACC GGC AAG CTT CAC TGC CCG GCC GAC GTG TGC GGG CCG CTC TAC GAG GAG GAG 
Leu Ala Phe Trp 61~ 
CTG GCC TTC TGG GGC 
Ile Asp Glu Thr Asp Val Glu Pro 
ATC GAC GAG ACG GAC GTG GAG CCC 
Cys Trp Met Thr Tyr 
TGC TGG ATG ACC TAT 
110 
Arg Gln His Arg Asp 
CGC CAG CAC CGA GAC 
Ala Glu Glu Ala Leu 
GCT GAG GAG GCG CTG 
120 
Asp 
GAC 
130 140 150 
Ser Phe Gly Gly Ala Pro Leu Asp Asn Ser Ala Asp Asp Ala Asp Ala Asp Gly Pro Gly Asp Ser Gly Asp Gly Glu Asp Glu Leu Glu 
AGC TTT GGC GGT GCG CCC TTG GAC AAC AGC GCC GAC GAC GCG GAC GCC GAC GGC CCC GGC GAC TCG GGC GAC GGC GAG GAC GAG CTG GAG 
160 170 180 
Met Thr Lys Arg Leu Ala Leu Ser Asp Ser Pro Asp Gly Arg Pro Gly Gly Phe Trp Arg Arg Trp Gln Pro Arg Ile Trp Ala Leu Phe 
ATG ACC AAG AGA TTG GCA CTC AGT GAC TCC CCA GAT GGC CGG CCT GGC GGC TTC TGG CGC CGC TGG CAA CCG CGC ATC TGG GCG CTG TTC 
190 200 51 210 
Glu Asp Pro Tyr Ser Ser Arg Tyr Ala Arg Tyr Val Al Ph Al S L Ph Ph I1 L V 1 S I1 Th Th Ph e Cys Leu Glu 
GAG GAC CCC TAC TCA TCC CGC TAC GCG CGG TAT GTG GC: TT: GC: Tfj,' d"c TT: TTt AT: C:!i GfC T:: AT: AC; AC: TTC TGT CTG GAG 
220 230 240 
Thr His Glu Arg Phe Am Pro Ile Val Asn Lys Thr Glu Ile Glu Asn Val Arg Asn Gly Thr Gln Val Arg Tyr Tyr Arg Glu Ala Glu 
ACT CAC GAG CGC TTC AAC CCC ATC GTG AAC AAG ACC GAA ATC GAG AAC GTT CGA AAC GGC ACC CAA GTG CGG TAC TAC CGG GAA GCA GAG 
250 52 260 270 
Thr Glu Ala Phe Leu Thr Tyr Ile Glu Gl V 1 C V 1 V 1 T Ph Th Ph Gl Ph e Leu Met Arg Val V 1 Phe Cys Pro Asn Lys 
ACG GAG GCC TTC CTC ACC TAC ATC GAG GG: G:C T:; G:G G:C T;! TT: AC: TT: GA: TTC CTC ATG CGT GTC GfC TTC TGC CCC AAC AAG 
280 53 290 300 
Val Glu Phe Ile Lys Asn Ser Leu Asn Ile I1 
GTG GAA TTC ATC AAG AAC TCC CTC AAT ATC ATT GAC TTT GTG GC: AT: Cf: CL: TT: Ti: CT: GA: G+G GGC CTA AGC GGC CTG TCC TCA 
e Asp Phe Val Al 11 L P Ph T L Gl V 1 Gly Leu Ser Gly Leu Ser Ser 
310 320 54 330 
Lys Ala Ala Lys Asp Val Leu Gly phe Leu Arg Val V 1 A Ph V 1 A I1 L A I1 Ph L L Th A Hi Ph V 1 Gl 
AAA GCC GCC AAG GAC GTT CTG GGC TTC CTG CGC GTC G:C CL: TT: GtG C:& AT: C;; C:: AT: TT: Ai; C:: AC: C:: CA: TT: G:G GG: 
340 350 55 360 
E Arg Val Leu Gly His Thr Leu Arg Ala Ser Thr Asn Glu Phe Leu Leu Leu Ile Ile Phe Leu Ala Leu Gly Val Leu Ile Phe Ala 
CTG AGG GTC CTG GGC CAC ACG CTC CGT GCC AGC ACC AAC GAG TTC CTG CTG CTT ATC ATC TTC CTG GCC CTG GGA GTG CTC ATC TTT GCC 
370 380 390 
fhr Met Ile Tyr Tyr Ala Glu Arg Ile Gly Ala Gln Pro Asn Asp Pro Ser Ala Ser Glu His Thr His Phe Lys Asn Ile Pro Ile Gly 
ACC ATG ATC TAC TAC GCC GAG AGG ATA GGG GCA CAG CCC AAT GAC CCC AGC GCC AGC GAA CAC ACA CAC TTT AAA AAC ATC CCC ATC GGC 
400 410 420 
Phe Trp Trp Ala Val Val Thr Met Thr Thr Leu Gly Tyr Gly Asp Met Tyr Pro Gln Thr Trp Ser Gly Met Leu Val Gl Al L C 
TTC TGG TGG GCT GTG GTC ACC ATG ACG ACA CTG GGC TAT GGA GAC ATG TAT CCC CAG ACG TGG TCT GGA ATG CTG GTG GG; GC: Tit T:f 
56 430 440 450 
Ala Leu Ala Gl V 1 L Th 11 Ala Met Pro Val P V 1 I1 e VaT Asn Asn Phe Gly Met Tyr Tyr Ser Leu Ala Met Ala Lys Gln 
GCT CTG GCT GG; G:G CT: AC: AT; GCC ATG CCG GTG C;: G:C ATC GTG AAC AAT TTT GGG ATG TAC TAC TCT TTA GCC ATG GCT AAG CAG 
460 470 480 
Lys Leu Pro Lys Lys Lys Lys Lys HIS Ile Pro Arg Pro Pro Gln Leu Gly Ser Pro Asn Tyr Cys Lys Ser Val Val Asn Ser Pro His 
AAA CTA CCA AAG AAA AAA AAG AAG CAT ATT CCG CGG CCA CCA CAG CTG GGA TCT CCC AAT TAT TGT AAA TCT GTC GTA AAC TCT CCA CAC 
490 500 510 
His Ser Thr Gln Ser Asp Thr Cys Pro Leu Ala Gin Glu Glu Ile Leu Glu Ile Asn Arg Ala Gly Arg Lys Pro Leu Arg Gly Met Ser 
CAC AGT ACT CAG AGT GAC ACA TGC CCG CTG GCC CAG GAA GAA ATT TTA GAA ATT AAC AGA GCA GGT AGG AAA CCT CTC AGA GGC ATG TCG 
Ile 
ATC TGA CCTTTCACCTCCGCCCCCTGTAGCAATGATTCCAGATCCAGTCAGACTGCTTCCTTAGTTCCACGGGCGACCCAGGATCCTGTGCCC~CTTTGAGTTGTGGAGCCTGGGAC 
CCCAGGGAGATGCTGGGCGGC-----3' 
-1 
go 
180 
270 
360 
450 
540 
630 
720 
810 
900 
990 
1080 
1170 
1260 
1350 
1440 
1530 
1648 
Fig.1. Nucleotide sequence of the cDNA encoding the NGK2 protein and the deduced amino acid sequence. The nucleotide sequence was 
determined using clones ANGKZ. 18Al (carrying nucleotides - 136 to 1014), hNGK2.19A4 (665-1669) and ANGK2.5Bl (925-1362). Nucleotide 
residues are numbered in the 5’ to 3’ direction from the first residue of the ATG initiation triplet and the preceding residues are indicated by 
negative numbers. Numbers of the nucleotide residues at the right-hand end of the individual lines are given. Amino acid residues are numbered 
from the intitiating methionine. The putative transmembrane segments M-S6 are overlined; the termini of each segment have been tentatively 
assigned. 
Large outward currents were elicited in injected oocytes 
upon depolarization from a holding potential of - 60 
mV under voltage clamp (fig.4A,B). The size of the cur- 
rent at 0 mV was 18.0+ 10.7pA (meankSD, n=29) for 
oocytes injected with the NGKl-specific mRNA and 
25.4-t 10.9 /IA (n=26) for oocytes injected with the 
NGKZ-specific mRNA. Under the same experimental 
conditions, non-injected oocytes showed small outward 
currents, but the size of the current was at most 0.15 PA 
(0.071tO.05 /IA, n= 30). When the test potential was 
varied, the outward current began to appear at - 30 mV 
in oocytes injected with the NGKl-specific mRNA, 
whereas the outward current was elicited only at more 
positive potentials in oocytes injected with the 
NGKZspecific mRNA (fig.4A-C). The outward cur- 
rents in oocytes injected with the NGKl-specific and 
with the NGKZspecific mRNA showed fast activation, 
attaining maximal amplitudes in tens of milliseconds, 
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Fig.2. Alignment of the amino acid sequences of different potassium channel proteins. The one-letter amino acid notation is used. The seven 
sequences compared (from top to bottom) are as follows: NGKZ; Shaw2 [6]; RCK! [8]; BK2 [9] (NGK!); ShAl [2]; drkl [lo]; Grab1 1 [6]. Amino 
acid residues are numbered from the initiating methionine, and numbers of the residues on each line are given on the right-hand side. Sets of seven 
identical residues at one aligned position are enclosed with solid lines, and sets of seven identical or conservative residues [31] at one aligned position 
with broken lines. Highly divergent segments are represented by the sum of residues in each segment given in parentheses. For evaluating sequence 
similarity, a continuous tretch of gaps (-) was counted as one substitution regardless of its length. The positions of segments Sl-S6 are indicated 
(see the legend to fig.1). 
but were inactivated very slowly during l-s voltage steps 
to 0 mV, the decrease in current size being 9-t 3% (n = 9) 
and 13 f 7% (n = 9) of the peak value, respectively. 
Ion substitution experiments howed that the reversal 
potential of the tail currents shifted by + 55.6* 1.8 mV 
(n=6) and by + 53.1k2.0 mV (n=6) per lo-fold in- 
crease of external K+ concentration, respectively, in 
oocytes injected with the NGKl-specific and with the 
NGKZspecific mRNA. These values are close to the 
theoretical value of + 58.6 mV, calculated from the 
Nernst equation, and indicate that the outward currents 
observed in injected oocytes are carried by potassium 
ions. 
The outward currents were examined for sensitivity 
to pharmacological agents added to the bathing solu- 
tion. The concentrations required for inhibiting the cur- 
rents by 50% (I&) were as follows (the former and lat- 
ter values refer to oocytes injected with the 
NGKl-specific and with the NGKZspecific mRNA, 
respectively): 0.2 mM and 0.6 mM 4-aminopyridine; 
> 10 mM and 0.1 mM tetraethylammonium; and 0.8 
mM and 1 mM quinine. Apamin (1 PM) and 
tolbutamide (100 ,uM) were ineffective. 
Single-channel currents were recorded from inside- 
out membrane patches isolated from injected oocytes 
using a nominally Ca’+-free K+ solution on the 
cytoplasmic side (fig.4D,E). The channel in patches of 
oocytes injected with the NGKI-specific mRNA showed 
a slope conductance of 17.5kO.4 pS (5 patches), but 
smaller conductance levels were frequently observed 
NGK2 
Shaw 
FiCKl 
BK2 
Shaker 
Shab 
Fig.3. Phylogenetic tree of the potasium channel family. The 
neighbor-joining method [30] was used; the calculation procedure for 
the phylogenetic tree inference has been described previously [32]. 
The deepest root ‘a’ was determined by comparing the amino acid 
sequences of the potassium channel proteins with those of sodium 
channels and calcium channels (data not shown). Lengths of 
horizontal lines of the tree are proportional to estimated numbers of 
amino acid substitutions. 
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A 
5Oms 
v 0-M 
B r- 
50 ms 
Fig.4. Properties of outward currents in Xenopus oocytes injected with the NGKl-specific and with the NGKZ-specific mRNA. (A,B) Outward 
currents in response to depolarizing voltage steps in an oocyte injected with the NGK-1 specific mRNA (A) or with the NGKZ-specific mRNA (B). 
The membrane potential was held at - 60 mV and stepped to test potentials ranging from - 40 mV to + 20 mV in IO-mV increments. In B, 
overlapping records were obtained upon depolarization to - 40 mV, - 30 mV and - 20 mV. (C) The whole-cell current-voltage relation obtained 
from an oocyte injected with the NGKl-specific mRNA (circles) or with the NGKZ-specific mRNA (squares). The oocytes used for C were different 
from those used for A and B. (D,E) Single-channel currents from an oocyte injected with the NGKl-specific mRNA (D) or with the NGKZ-specific 
mRNA (E). Inside-out patch. Outward current upwards. Membrane potential, 0 mV. Records were low-pass filtered at 0.1 kHz and sampled at 
0.25 kHz. 
(fig.4D). The channel in patches of oocytes injected 
with the NGKZspecific mRNA showed a larger slope 
conductance (26.4+ 1.7 pS; 6 patches), and subconduc- 
tance levels rarely occurred (fig.4E). 
The cDNA expression studies indicate that both the 
NGK2 protein, which is closely related to the 
Drosophila Shaw gene product, and the NGKl protein, 
which is a member of the RCKl . BIWShaker subfami- 
ly, form potassium channels with properties of delayed 
rectifiers, although the NGK2 and NGKl potassium 
channels exhibit some kinetic and pharmacological dif- 
ferences. It has been reported that Drosophila Shaker 
cDNAs are expressed to produce A-type potassium 
channels [12-141, while expression of mammalian 
RCKl and related cDNAs of the same subfamily yields 
potassium channels with properties of delayed rectifiers 
and possibly A-type channels [ 11,15,16]. The drk 1 pro- 
tein, which is a mammalian counterpart of the 
Drosophila Shab gene product, is expressed as a 
delayed rectifier class channel [lo]. The molecular basis 
for the electrophysiological differences between these 
voltage-gated potassium channels remains to be 
elucidated. 
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